{
    "code": "52026106",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026106",
    "time": "2018-07-20 04:10:35",
    "許可證字號": "衛部藥輸字第026106號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/05\/29",
    "註銷理由": "自請註銷",
    "有效日期": "107\/08\/02",
    "發證日期": "102\/08\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202610605",
    "中文品名": "歐潰寧&quot;山德士&quot;凍晶注射劑40毫克",
    "英文品名": "Esomeprazole Sandoz Powder for Solution for Injection\/Infusion 40mg",
    "適應症": "-用於不適合使用口服治療時之替代治療-胃食道逆流性疾病，於食道炎及\/或有嚴重逆流症狀之病患-NSAID治療相關之胃潰瘍的治療-於治療性內視鏡處置急性出血胃潰瘍或十二指腸潰瘍之後預防再出血。",
    "劑型": "243凍晶注射劑",
    "包裝": "40毫克玻璃小瓶裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "ESOMEPRAZOLESODIUM"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F530003000  LEK PHARMACEUTICALS D.D",
        "製造廠廠址": "VEROVSKOVA 57, SL-1526 LJUBLJANA, SLOVENIA",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640002920",
            "成分名稱": "ESOMEPRAZOLE SODIUM",
            "含量描述": "(eq. to Esomeprazole 40mg)",
            "含量": "42.5600000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI_TWI091713-104-09-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026106&Seq=002&Type=9"
        },
        {
            "title": "FB-104-09-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026106&Seq=004&Type=8"
        }
    ]
}